Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 182

1.

Investigating supramolecular systems using Förster resonance energy transfer.

Teunissen AJP, Pérez-Medina C, Meijerink A, Mulder WJM.

Chem Soc Rev. 2018 Aug 9. doi: 10.1039/c8cs00278a. [Epub ahead of print] Review.

PMID:
30091770
2.

Sonophore-enhanced nanoemulsions for optoacoustic imaging of cancer.

Roberts S, Andreou C, Choi C, Donabedian P, Jayaraman M, Pratt EC, Tang J, Pérez-Medina C, Jason de la Cruz M, Mulder WJM, Grimm J, Kircher M, Reiner T.

Chem Sci. 2018 May 18;9(25):5646-5657. doi: 10.1039/c8sc01706a. eCollection 2018 Jul 7.

3.

Development and Multiparametric Evaluation of Experimental Atherosclerosis in Rabbits.

Senders ML, Lobatto ME, Soler R, Lairez O, Pérez-Medina C, Calcagno C, Fayad ZA, Mulder WJM, Fay F.

Methods Mol Biol. 2018;1816:385-400. doi: 10.1007/978-1-4939-8597-5_30.

PMID:
29987836
4.

Can education improve clinical practice concerning delirium in older hospitalised patients? Results of a pre-test post-test study on an educational intervention for nursing staff.

van Velthuijsen EL, Zwakhalen SMG, Warnier RMJ, Ambergen T, Mulder WJ, Verhey FRJ, Kempen GIJM.

BMC Med Educ. 2018 Apr 2;18(1):59. doi: 10.1186/s12909-018-1177-3.

5.

Reversible Electroporation-Mediated Liposomal Doxorubicin Delivery to Tumors Can Be Monitored With 89Zr-Labeled Reporter Nanoparticles.

Srimathveeravalli G, Abdel-Atti D, Pérez-Medina C, Takaki H, Solomon SB, Mulder WJM, Reiner T.

Mol Imaging. 2018 Jan-Dec;17:1536012117749726. doi: 10.1177/1536012117749726.

6.

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis.

Seijkens TTP, van Tiel CM, Kusters PJH, Atzler D, Soehnlein O, Zarzycka B, Aarts SABM, Lameijer M, Gijbels MJ, Beckers L, den Toom M, Slütter B, Kuiper J, Duchene J, Aslani M, Megens RTA, van 't Veer C, Kooij G, Schrijver R, Hoeksema MA, Boon L, Fay F, Tang J, Baxter S, Jongejan A, Moerland PD, Vriend G, Bleijlevens B, Fisher EA, Duivenvoorden R, Gerdes N, de Winther MPJ, Nicolaes GA, Mulder WJM, Weber C, Lutgens E.

J Am Coll Cardiol. 2018 Feb 6;71(5):527-542. doi: 10.1016/j.jacc.2017.11.055.

7.

Effects of a Medication Review on Delirium in Older Hospitalised Patients: A Comparative Retrospective Cohort Study.

van Velthuijsen EL, Zwakhalen SMG, Pijpers E, van de Ven LI, Ambergen T, Mulder WJ, Verhey FRJ, Kempen GIJM.

Drugs Aging. 2018 Feb;35(2):153-161. doi: 10.1007/s40266-018-0523-9.

8.

PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.

Senders ML, Que X, Cho YS, Yeang C, Groenen H, Fay F, Calcagno C, Meerwaldt AE, Green S, Miu P, Lobatto ME, Reiner T, Fayad ZA, Witztum JL, Mulder WJM, Pérez-Medina C, Tsimikas S.

J Am Coll Cardiol. 2018 Jan 23;71(3):321-335. doi: 10.1016/j.jacc.2017.11.036.

9.

Neutrophil derived CSF1 induces macrophage polarization and promotes transplantation tolerance.

Braza MS, Conde P, Garcia M, Cortegano I, Brahmachary M, Pothula V, Fay F, Boros P, Werner SA, Ginhoux F, Mulder WJM, Ochando J.

Am J Transplant. 2018 May;18(5):1247-1255. doi: 10.1111/ajt.14645. Epub 2018 Feb 7.

10.

High-Density Lipoprotein Nanobiologics for Precision Medicine.

Mulder WJM, van Leent MMT, Lameijer M, Fisher EA, Fayad ZA, Pérez-Medina C.

Acc Chem Res. 2018 Jan 16;51(1):127-137. doi: 10.1021/acs.accounts.7b00339. Epub 2017 Dec 27.

PMID:
29281244
11.

RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.

Hogstad B, Berres ML, Chakraborty R, Tang J, Bigenwald C, Serasinghe M, Lim KPH, Lin H, Man TK, Remark R, Baxter S, Kana V, Jordan S, Karoulia Z, Kwan WH, Leboeuf M, Brandt E, Salmon H, McClain K, Poulikakos P, Chipuk J, Mulder WJM, Allen CE, Merad M.

J Exp Med. 2018 Jan 2;215(1):319-336. doi: 10.1084/jem.20161881. Epub 2017 Dec 20.

12.

The use of an electronic clinical rule to discontinue chronically used benzodiazepines and related Z drugs.

Mestres Gonzalvo C, Milosevic V, van Oijen BPC, de Wit HAJM, Hurkens KPGM, Mulder WJ, Janknegt R, Schols JMGA, Verhey FR, Winkens B, van der Kuy PHM.

Eur J Clin Pharmacol. 2018 Feb;74(2):227-231. doi: 10.1007/s00228-017-2369-1. Epub 2017 Nov 10.

PMID:
29127459
13.

Validation of an automated delirium prediction model (DElirium MOdel (DEMO)): an observational study.

Mestres Gonzalvo C, de Wit HAJM, van Oijen BPC, Deben DS, Hurkens KPGM, Mulder WJ, Janknegt R, Schols JMGA, Verhey FR, Winkens B, van der Kuy PM.

BMJ Open. 2017 Nov 8;7(11):e016654. doi: 10.1136/bmjopen-2017-016654.

14.

Cardiovascular Immunotherapy and the Role of Imaging.

Zupančič E, Fayad ZA, Mulder WJM.

Arterioscler Thromb Vasc Biol. 2017 Nov;37(11):e167-e171. doi: 10.1161/ATVBAHA.117.309227. Review. No abstract available.

PMID:
29070539
15.

Specific Binding of Liposomal Nanoparticles through Inverse Electron-Demand Diels-Alder Click Chemistry.

Brand C, Iacono P, Pérez-Medina C, Mulder WJM, Kircher MF, Reiner T.

ChemistryOpen. 2017 Aug 7;6(5):615-619. doi: 10.1002/open.201700105. eCollection 2017 Oct.

16.

Integrating nanomedicine and imaging.

Pérez-Medina C, Hak S, Reiner T, Fayad ZA, Nahrendorf M, Mulder WJM.

Philos Trans A Math Phys Eng Sci. 2017 Nov 28;375(2107). pii: 20170110. doi: 10.1098/rsta.2017.0110. Review.

PMID:
29038380
17.

The Maastricht Frailty Screening Tool for Hospitalised Patients (MFST-HP) to Identify Non-Frail Patients.

Warnier RMJ, van Rossum E, van Kuijk SMJ, Mulder WJ, Schols JMGA, Kempen GIJM.

Int J Clin Pract. 2017 Sep;71(9). doi: 10.1111/ijcp.13003. Epub 2017 Sep 8.

PMID:
28885763
18.

Cancer Immunotherapy: From local to global.

Mulder WJM, Gnjatic S.

Nat Nanotechnol. 2017 Sep 6;12(9):840-841. doi: 10.1038/nnano.2017.196. No abstract available.

PMID:
28875982
19.

A systematic comparison of clinically viable nanomedicines targeting HMG-CoA reductase in inflammatory atherosclerosis.

Alaarg A, Senders ML, Varela-Moreira A, Pérez-Medina C, Zhao Y, Tang J, Fay F, Reiner T, Fayad ZA, Hennink WE, Metselaar JM, Mulder WJM, Storm G.

J Control Release. 2017 Sep 28;262:47-57. doi: 10.1016/j.jconrel.2017.07.013. Epub 2017 Jul 9.

20.

Energy consumption and water-soluble protein release by cell wall disruption of Nannochloropsis gaditana.

Safi C, Cabas Rodriguez L, Mulder WJ, Engelen-Smit N, Spekking W, van den Broek LAM, Olivieri G, Sijtsma L.

Bioresour Technol. 2017 Sep;239:204-210. doi: 10.1016/j.biortech.2017.05.012. Epub 2017 May 5.

21.

Applying nanomedicine in maladaptive inflammation and angiogenesis.

Alaarg A, Pérez-Medina C, Metselaar JM, Nahrendorf M, Fayad ZA, Storm G, Mulder WJM.

Adv Drug Deliv Rev. 2017 Sep 15;119:143-158. doi: 10.1016/j.addr.2017.05.009. Epub 2017 May 12. Review.

PMID:
28506745
22.

Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis.

Beldman TJ, Senders ML, Alaarg A, Pérez-Medina C, Tang J, Zhao Y, Fay F, Deichmöller J, Born B, Desclos E, van der Wel NN, Hoebe RA, Kohen F, Kartvelishvily E, Neeman M, Reiner T, Calcagno C, Fayad ZA, de Winther MPJ, Lutgens E, Mulder WJM, Kluza E.

ACS Nano. 2017 Jun 27;11(6):5785-5799. doi: 10.1021/acsnano.7b01385. Epub 2017 May 15.

23.

Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging.

Fay F, Hansen L, Hectors SJCG, Sanchez-Gaytan BL, Zhao Y, Tang J, Munitz J, Alaarg A, Braza MS, Gianella A, Aaronson SA, Reiner T, Kjems J, Langer R, Hoeben FJM, Janssen HM, Calcagno C, Strijkers GJ, Fayad ZA, Pérez-Medina C, Mulder WJM.

Bioconjug Chem. 2017 May 17;28(5):1413-1421. doi: 10.1021/acs.bioconjchem.7b00086. Epub 2017 May 5.

24.

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines.

Tang J, Pérez-Medina C, Zhao Y, Sadique A, Mulder WJ, Reiner T.

J Vis Exp. 2017 Mar 4;(121). doi: 10.3791/55271.

25.

Detection and management of hyperactive and hypoactive delirium in older patients during hospitalization: a retrospective cohort study evaluating daily practice.

van Velthuijsen EL, Zwakhalen SM, Mulder WJ, Verhey FR, Kempen GI.

Int J Geriatr Psychiatry. 2017 Feb 14. doi: 10.1002/gps.4690. [Epub ahead of print]

PMID:
28194812
26.

Supporting clinical rules engine in the adjustment of medication (SCREAM): protocol of a multicentre, prospective, randomised study.

Mestres Gonzalvo C, de Wit HA, van Oijen BP, Hurkens KP, Janknegt R, Schols JM, Mulder WJ, Verhey FR, Winkens B, van der Kuy PM.

BMC Geriatr. 2017 Jan 26;17(1):35. doi: 10.1186/s12877-017-0426-3.

27.

Real-Time Monitoring of Nanoparticle Formation by FRET Imaging.

Sanchez-Gaytan BL, Fay F, Hak S, Alaarg A, Fayad ZA, Pérez-Medina C, Mulder WJ, Zhao Y.

Angew Chem Int Ed Engl. 2017 Mar 6;56(11):2923-2926. doi: 10.1002/anie.201611288. Epub 2017 Jan 23.

28.

Polyglucose nanoparticles with renal elimination and macrophage avidity facilitate PET imaging in ischaemic heart disease.

Keliher EJ, Ye YX, Wojtkiewicz GR, Aguirre AD, Tricot B, Senders ML, Groenen H, Fay F, Perez-Medina C, Calcagno C, Carlucci G, Reiner T, Sun Y, Courties G, Iwamoto Y, Kim HY, Wang C, Chen JW, Swirski FK, Wey HY, Hooker J, Fayad ZA, Mulder WJ, Weissleder R, Nahrendorf M.

Nat Commun. 2017 Jan 16;8:14064. doi: 10.1038/ncomms14064.

29.

Relation between resting amygdalar activity and cardiovascular events: a longitudinal and cohort study.

Tawakol A, Ishai A, Takx RA, Figueroa AL, Ali A, Kaiser Y, Truong QA, Solomon CJ, Calcagno C, Mani V, Tang CY, Mulder WJ, Murrough JW, Hoffmann U, Nahrendorf M, Shin LM, Fayad ZA, Pitman RK.

Lancet. 2017 Feb 25;389(10071):834-845. doi: 10.1016/S0140-6736(16)31714-7. Epub 2017 Jan 12. Erratum in: Lancet. 2017 Feb 25;389(10071):804. Lancet. 2017 Feb 25;389(10071):804.

PMID:
28088338
30.

Near-Infrared Quantum Dot and 89Zr Dual-Labeled Nanoparticles for in Vivo Cerenkov Imaging.

Zhao Y, Shaffer TM, Das S, Pérez-Medina C, Mulder WJ, Grimm J.

Bioconjug Chem. 2017 Feb 15;28(2):600-608. doi: 10.1021/acs.bioconjchem.6b00687. Epub 2017 Jan 12.

31.

Biorefinery of microalgal soluble proteins by sequential processing and membrane filtration.

Safi C, Olivieri G, Campos RP, Engelen-Smit N, Mulder WJ, van den Broek LAM, Sijtsma L.

Bioresour Technol. 2017 Feb;225:151-158. doi: 10.1016/j.biortech.2016.11.068. Epub 2016 Nov 18.

32.

Imaging-guided revival of nanomedicine?

Senders ML, Fayad ZA, Reiner T, Mulder WJ, Pérez-Medina C.

Nanomedicine (Lond). 2017 Jan;12(2):89-90. Epub 2016 Nov 23. No abstract available.

33.

Immune cell screening of a nanoparticle library improves atherosclerosis therapy.

Tang J, Baxter S, Menon A, Alaarg A, Sanchez-Gaytan BL, Fay F, Zhao Y, Ouimet M, Braza MS, Longo VA, Abdel-Atti D, Duivenvoorden R, Calcagno C, Storm G, Tsimikas S, Moore KJ, Swirski FK, Nahrendorf M, Fisher EA, Pérez-Medina C, Fayad ZA, Reiner T, Mulder WJ.

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6731-E6740. Epub 2016 Oct 17.

34.

Conformational Changes in High-Density Lipoprotein Nanoparticles Induced by High Payloads of Paramagnetic Lipids.

Ramos-Cabrer P, Fay F, Sanchez-Gaytan BL, Tang J, Castillo J, Fayad ZA, Mulder WJ.

ACS Omega. 2016 Sep 30;1(3):470-475. Epub 2016 Sep 26.

35.

Screening for Frailty in Hospitalized Older Adults: Reliability and Feasibility of the Maastricht Frailty Screening Tool for Hospitalized Patients (MFST-HP).

Warnier RM, van Rossum E, van Leendert JA, Pijls NA, Mulder WJ, Schols JM, Kempen GI.

Res Gerontol Nurs. 2016 Sep 1;9(5):243-51. doi: 10.3928/19404921-20160906-01.

PMID:
27637112
36.

The support of medication reviews in hospitalised patients using a clinical decision support system.

de Wit HA, Hurkens KP, Mestres Gonzalvo C, Smid M, Sipers W, Winkens B, Mulder WJ, Janknegt R, Verhey FR, van der Kuy PH, Schols JM.

Springerplus. 2016 Jun 24;5(1):871. doi: 10.1186/s40064-016-2376-1. eCollection 2016.

37.

Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.

Pérez-Medina C, Abdel-Atti D, Tang J, Zhao Y, Fayad ZA, Lewis JS, Mulder WJ, Reiner T.

Nat Commun. 2016 Jun 20;7:11838. doi: 10.1038/ncomms11838.

38.

HDL mimetic CER-001 targets atherosclerotic plaques in patients.

Zheng KH, van der Valk FM, Smits LP, Sandberg M, Dasseux JL, Baron R, Barbaras R, Keyserling C, Coolen BF, Nederveen AJ, Verberne HJ, Nell TE, Vugts DJ, Duivenvoorden R, Fayad ZA, Mulder WJM, van Dongen GAMS, Stroes ESG.

Atherosclerosis. 2016 Aug;251:381-388. doi: 10.1016/j.atherosclerosis.2016.05.038. Epub 2016 May 27.

39.

In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.

Pérez-Medina C, Binderup T, Lobatto ME, Tang J, Calcagno C, Giesen L, Wessel CH, Witjes J, Ishino S, Baxter S, Zhao Y, Ramachandran S, Eldib M, Sánchez-Gaytán BL, Robson PM, Bini J, Granada JF, Fish KM, Stroes ES, Duivenvoorden R, Tsimikas S, Lewis JS, Reiner T, Fuster V, Kjær A, Fisher EA, Fayad ZA, Mulder WJ.

JACC Cardiovasc Imaging. 2016 Aug;9(8):950-61. doi: 10.1016/j.jcmg.2016.01.020. Epub 2016 May 25.

40.

The development of an automated ward independent delirium risk prediction model.

de Wit HA, Winkens B, Mestres Gonzalvo C, Hurkens KP, Mulder WJ, Janknegt R, Verhey FR, van der Kuy PH, Schols JM.

Int J Clin Pharm. 2016 Aug;38(4):915-23. doi: 10.1007/s11096-016-0312-7. Epub 2016 May 13.

PMID:
27177868
41.

Augmenting drug-carrier compatibility improves tumour nanotherapy efficacy.

Zhao Y, Fay F, Hak S, Manuel Perez-Aguilar J, Sanchez-Gaytan BL, Goode B, Duivenvoorden R, de Lange Davies C, Bjørkøy A, Weinstein H, Fayad ZA, Pérez-Medina C, Mulder WJ.

Nat Commun. 2016 Apr 13;7:11221. doi: 10.1038/ncomms11221.

42.

Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis.

van der Valk FM, Schulte DM, Meiler S, Tang J, Zheng KH, Van den Bossche J, Seijkens T, Laudes M, de Winther M, Lutgens E, Alaarg A, Metselaar JM, Dallinga-Thie GM, Mulder WJ, Stroes ES, Hamers AA.

Nanomedicine. 2016 Aug;12(6):1463-70. doi: 10.1016/j.nano.2016.02.022. Epub 2016 Mar 23.

PMID:
27015770
43.

Nanomedicines for Endothelial Disorders.

Chung BL, Toth MJ, Kamaly N, Sei YJ, Becraft J, Mulder WJ, Fayad ZA, Farokhzad OC, Kim Y, Langer R.

Nano Today. 2015 Dec 1;10(6):759-776.

44.

Peritoneal dialysis in centenarian patients: no age limitation?

Litjens EJ, Mulder WJ, Peppelenbosch NG, Cornelis T.

J Vasc Access. 2016 Mar;17 Suppl 1:S53-5. doi: 10.5301/jva.5000499. Epub 2016 Mar 6.

PMID:
26951905
45.

Psychometric properties and feasibility of instruments for the detection of delirium in older hospitalized patients: a systematic review.

van Velthuijsen EL, Zwakhalen SM, Warnier RM, Mulder WJ, Verhey FR, Kempen GI.

Int J Geriatr Psychiatry. 2016 Sep;31(9):974-89. doi: 10.1002/gps.4441. Epub 2016 Feb 21. Review.

PMID:
26898375
46.

Systems Biology and Noninvasive Imaging of Atherosclerosis.

Calcagno C, Mulder WJ, Nahrendorf M, Fayad ZA.

Arterioscler Thromb Vasc Biol. 2016 Feb;36(2):e1-8. doi: 10.1161/ATVBAHA.115.306350. Review. No abstract available.

47.

Validity, Reliability and Feasibility of Tools to Identify Frail Older Patients in Inpatient Hospital Care: A Systematic Review.

Warnier RM, van Rossum E, van Velthuijsen E, Mulder WJ, Schols JM, Kempen GI.

J Nutr Health Aging. 2016 Feb;20(2):218-30. doi: 10.1007/s12603-015-0567-z. Review.

PMID:
26812520
48.

Combination nanotherapy penetrates atherosclerosis.

Mulder WJ.

Cardiovasc Res. 2016 Feb 1;109(2):191-2. doi: 10.1093/cvr/cvv271. Epub 2015 Dec 17. No abstract available.

PMID:
26678357
49.

Imaging Macrophage and Hematopoietic Progenitor Proliferation in Atherosclerosis.

Ye YX, Calcagno C, Binderup T, Courties G, Keliher EJ, Wojtkiewicz GR, Iwamoto Y, Tang J, Pérez-Medina C, Mani V, Ishino S, Johnbeck CB, Knigge U, Fayad ZA, Libby P, Weissleder R, Tawakol A, Dubey S, Belanger AP, Di Carli MF, Swirski FK, Kjaer A, Mulder WJ, Nahrendorf M.

Circ Res. 2015 Oct 23;117(10):835-45. doi: 10.1161/CIRCRESAHA.115.307024. Epub 2015 Sep 22.

50.

Three-dimensional dynamic contrast-enhanced MRI for the accurate, extensive quantification of microvascular permeability in atherosclerotic plaques.

Calcagno C, Lobatto ME, Dyvorne H, Robson PM, Millon A, Senders ML, Lairez O, Ramachandran S, Coolen BF, Black A, Mulder WJ, Fayad ZA.

NMR Biomed. 2015 Oct;28(10):1304-14. doi: 10.1002/nbm.3369. Epub 2015 Aug 30.

Supplemental Content

Loading ...
Support Center